Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,950.00
(
0.90%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,339.35
(
0.18%
)
News Focus
News Focus
Post# of 15168
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DR5

Send PM Follow Ignore
Followers 10
Posts 1118
Boards Moderated 0
Alias Born 01/05/2018

DR5

Re: rodman post# 1747

Wednesday, 11/14/2018 10:36:26 AM

Wednesday, November 14, 2018 10:36:26 AM

Post# of 15168
In this case, I would disagree. Pharma mergers are usually intended to secure the sales force in the new company. UEEC doesn’t have any type of sales force or infrastructure to buy. It’s only HemoStyp that the acquirer will want. I think this will be an all cash buyout. Our market cap is only $100mm or so. We’re “small potatoes” in the scheme of things to the big guys. IMO
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent UEEC News
More UEEC News